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Intensive care unit (ICU) patients are often overtly subjected to mechanical ventilation
and immobilization, which leads to impaired limb and respiratory muscle function.
The latter, termed ventilator-induced diaphragm dysfunction (VIDD) has recently been
related to compromised heat shock protein (Hsp) activation. The administration of
a pharmacological drug BGP-15 acting as a Hsp chaperone co-inducer has been
found to partially alleviate VIDD in young rats. Considering that the mean age in
the ICU is increasing, we aimed to explore whether the beneficial functional effects
are also present in old rats. For that, we exposed young (7–8 months) and old
(28–32 months) rats to 5-day controlled mechanical ventilation and immobilization with
or without systemic BGP-15 administration. We then dissected diaphragm muscles,
membrane–permeabilized bundles and evaluated the contractile function at single fiber
level. Results confirmed that administration of BGP-15 restored the force-generating
capacity of isolated muscle cells from young rats in conjunction with an increased
expression of Hsp72. On the other hand, our results highlighted that old rats did not
positively respond to the BGP-15 treatment. Therefore, it is of crucial importance to
comprehend in more depth the effect of VIDD on diaphragm function and ascertain any
further age-related differences.
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INTRODUCTION
Mechanical ventilation is a life-saving intervention in critically ill intensive care unit (ICU)
patients with respiratory failure. However, there is increasing evidence that assisted or controlled
mechanical ventilation (CMV) has significant negative effects on diaphragm muscle function that
elicits the condition known as ventilator-induced diaphragm dysfunction (VIDD) (Vassilakopoulos
and Petrof, 2004). Since VIDD has a strong impact on the ability of patients to be successfully
weaned from the ventilator, it is therefore of critical importance to understand the effect of
mechanical ventilation on diaphragm function (Laghi et al., 2003; Haitsma, 2011). A substantial
reduction in diaphragm muscle force-generation capacity has been reported in previous studies
using young mechanically ventilated baboons, rodents and piglets (Powers et al., 1985; Le
Bourdelles et al., 1994; Anzueto et al., 1997; Radell et al., 2002; Ochala et al., 2011; Corpeno et al.,
2014). Although the supportive therapy in ICUs has greatly improved during the last decades,
recent epidemiological studies have shown that older ICU patients are at greater risk of developing
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lung diseases and VIDD (Rubenfeld et al., 2005). Detailed
information on the effects of aging and mechanical ventilation
is limited, even though the age-related muscle wasting, termed
“sarcopenia” is known to be detrimental for diaphragm force
production in small mammals (Gosselin et al., 1994; Criswell
et al., 1997) and humans (Polkey et al., 1997).
Heat shock proteins, are highly conserved molecules found
in all cellular organisms. Their primary role is to chaperone,
transport and fold proteins when cells are exposed to different
types of stress (Senf et al., 2008). The protective role of Hsp’s
against immobilization-induced limb muscle wasting has been
reported in young animals (Aare et al., 2004; Banduseela et al.,
2009). The Hsp70 family constitutes the most conserved and
best-studied class of Hsp’s. Hsp70 promotes protein folding
and has been suggested to prevent and/or repair stress-induced
protein damage. The stress-inducible isoform of Hsp70 (Hsp72)
is generally not expressed in unstressed cells; however, upon
exposure to stressful conditions, Hsp72 is highly inducible.
During conditions of stress, Hsp72 is thought to bind to
damaged and miss folded polypeptides and further facilitate
repair (Lindquist and Craig, 1988). In addition, it has several
additional roles, including the regulation of various cell signaling
pathways related to cell growth and inflammation (Nollen and
Morimoto, 2002). At the skeletal muscle level, its specific up-
regulation maintains muscle fiber integrity and facilitates muscle
regeneration and recovery (Senf, 2013). The first evidence of
Hsp72’s involvement in regulating skeletal muscle size was
through the use of muscle specific Hsp70 transgenic mice
(McArdle et al., 2004). Furthermore, Hsp72 has been seen to
negatively regulate the Forkhead BoxO (FoxO) and Nuclear
Factor κB (NF-κB) pathways, which are activated during
numerous conditions of muscle atrophy (Hunter and Kandarian,
2004; Sandri et al., 2004; Senf et al., 2010).
Aged organisms exhibit a greatly decreased ability to
produce/activate Hsp’s in response to stresses, which correlate
with the increase in morbidity and mortality of aged organisms
(Heydari et al., 1994). Hsp72 has been reported to be decreased
in both adults and aged rats during periods of muscle disuse
(Dodd et al., 2009). Hence, aging and a wide variety of
pathophysiological and physiological conditions can be linked
to membrane changes which modulate membrane-controlled
molecular switches and consequently a dis-regulation of Hsp
expressions (Criswell et al., 2003). Based on these evidences, we
initially hypothesized that a drug that would directly target/up-
regulate Hsp’s would therefore be beneficial, with potentially a
greater positive effect in old organisms.
The non-toxic hydroxylamine (HA) derivatives amplify
the expression of Hsp’s induced by mild physical or
pathophysiological stresses, offering unique drug candidates,
potentially enhancing Hsp expression in diseased cells, without
significantly affecting healthy cells (Vigh et al., 2007; Gombos
et al., 2011). There is growing evidence that the production
of Hsp’s is triggered by the exposure to different kinds of
environmental stress conditions and is linked to changes in lipid
composition and in the architecture of membranes (Vigh et al.,
1998). A chaperone co-inducer is a substance that cannot induce
Hsp’s by itself, but can enhance Hsp induction in combination
with other mild stresses (Gombos et al., 2011). It has been
shown that the non-proteo-toxic, lipid interacting BGP-15
[O-(3-piperidino-2-hydroxy-1-propyl) nicotinic amidoxime
dihydrocholride], is capable of Hsp co-induction in the absence
of the production of unfolded proteins (Literati-Nagy et al.,
2012). The Hsp70 chaperone co-inducer BGP-15 was recently
shown to have a muscle sparing effect and improve muscle
architecture, strength and contractile function in severely
affected diaphragm muscles in in mdx mice (Gehrig et al.,
2012), as well as in young rats exposed to long-term mechanical
ventilation (Salah et al., 2016). What happens in old animals
remains to be studied and according to our hypothesis, we
believe that BGP-15 would have a potential beneficial effect
in old mechanically ventilated rats. Hence, the main aim of
this pilot study was to investigate the impact of BGP-15 on the
diaphragm contractile dysfunction in response to 5-day CMV in
young adult (7–8 months) and old (28–32 months) female 344
Brown Norway (F344-BN) hybrid rats.
MATERIALS AND METHODS
Animals
The diaphragm samples were collected from 17 F344-BN hybrid
rats, 7–8 months (young, n = 10) and 28–32 months (old, n =
7). The rats were obtained from the National Institute of Aging
(NIA Bethesda, MD). The rats were anesthetized, mechanically
ventilated and paralyzed by neuromuscular blockade (α-cobra-
toxin) for durations varying from 0 days (control) to 5 days. The
rats were randomly classified into three subgroups within young
and old. 4 young rats and 2 old rats, at time 0 days, 3 young, 2
old rats at time 5 days and 3 young, 3 old rats at time 5 days with
BGP-15.
Animals were maintained in protein and fluid balance; (1)
Intra-arterial solution: Alfa Cobra toxin (Biotoxins, St. Cloud,
Florida, FL, USA), Potassium chloride, Oxacillin (Fresenius Kabi,
Uppsala, Sweden), Heparin (Leo, Bellerup, Denmark), Ringers
(Potassium Chloride, Calcium Chloride, Sodium Chloride,
Lactate, (Fresenius Kabi)), Water; (2) Intra-venous solution:
Oxacillin (Fresenius Kabi), Ringers, Water, Glucose (Fresenius
Kabi) Vamin, (Fresenius Kabi) and Intralipid, (Fresenius Kabi),
and 40 mg/kg/day BGP-15 (N-gene). The sham-operated control
animals underwent the same interventions as the experimental
group, but they were not pharmacologically paralyzed with α-
cobra-toxin. That is, sham operated-controls were anesthetized
(isoflurane), spontaneously breathing, given intra-arterial and
intra-venous solutions, and sacrificed within 2 h after the initial
anesthesia and surgery.
The experimental model has previously been described in
detail (Dworkin and Dworkin, 2004) and modified to optimize
studies of skeletal muscle. Briefly; (1) Electrocardiogram (ECG)
electrodes were implanted subcutaneously. (2) An aortic catheter
(28-gauge Teflon) was inserted via the left carotid artery to
record arterial blood pressure. (3) A 0.9mm Renathane catheter
was threaded into the left jugular vein to administer parenteral
nutrition. (4) Three subcutaneous electroencephalogram (EEG)
needle electrodes were placed into the skull above the right and
left temporal lobes, and a third reference electrode was placed on
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the neck. (5) The rat was placed on a heating pad to maintain
body temperature; temperature was measured by a vaginal
thermistor and servo-regulated at 37◦C. (6) A silicone cannula
was inserted in the urethra to continuously record urine output.
Rats are ventilated through a per os coaxial tracheal cannula at
72 breaths/min with an inspiratory and expiratory ratio of 1:2
and a minute volume of 180–200 ml and gas concentrations
of 49.5% O2, 47% N2, and 3% CO2, delivered by a precision
(volume drift <1%/wk) volumetric respirator. Intermittent
hyperinflations (6 per h at 15 cmH2O), positive end-expiratory
pressure (1.5 cmH2O), and expiratory CO2 monitoring are
continuous. Neuromuscular block are induced on the first day
(100 µg iv. α-cobra-toxin) and maintained by continuous IV
infusion (250µg/day). Mechanical ventilation starts immediately
after the NMB induction. Experiments were terminated after 0
days (control) and 5 days (experimental). During surgery or any
possible irritating manipulation, the anesthetic isoflurane level is
at >1.5%. In no case did animals show any signs of infections,
septicemia, or systemic inflammation. The ethical committee at
Uppsala University and Karolinska Institutet approved all aspects
of this study.
Muscle Biopsies and Permeablisation of
Fibers
The diaphragm muscle was dissected immediately after
euthanasia. One half of the mid-costal diaphragm muscle was
frozen in liquid propane cooled by liquid nitrogen and stored
at −180◦C until further analyses. The other half was placed in
relaxing solution at 4◦C and bundles of∼50 fibers were dissected
free and tied with surgical silk to glass capillary tubes at slightly
stretched lengths. The bundles were then treated with skinning
solution (relaxing solution containing glycerol; 50:50 v/v) for 24
h at 4◦C, after which they were transferred to−20◦C.Within 1–2
weeks the muscle bundles were treated with a cryo-protectant
(sucrose), removed from the capillaries and snap frozen in liquid
nitrogen-chilled propane and stored at −180◦C for long term
storage.
Single Muscle Fiber Experimental
Procedure
On the day of the experiment, bundles were de-sucrosed;
transferred to a 2.0 M sucrose solution and subsequently
incubated in solutions of decreasing sucrose concentrations (1.5–
0.5M) for 30min each and finally kept in a skinning solution
at −20◦C. A single fiber was removed from the muscle bundle
and was placed between two connectors, at a length of 1 to
2mm long. One connector leads to a force transducer (model
400A, Aurora Scientific), and the other to a lever arm system
(model 308B, Aurora Scientific). The two extremities of the fiber
were tightly attached to the connectors as previously described
(Moss, 1979). The apparatus was mounted on the stage of an
inverted microscope (model IX70; Olympus). While the fiber
segments were in relaxing solution, the sarcomere length was
set to 2.65–2.75 µm by adjusting the overall segment length
and controlled during the experiment using a high-speed video
analysis system (model 901A HVSL, Aurora Scientific). The
diameter of the fiber segment between the connectors was
measured through the microscope at a magnification of ×
320 with an image analysis system prior to the mechanical
experiments. Fiber depth was measured by recording the vertical
displacement of the microscope nosepiece while focusing on
the top and bottom surfaces of the fiber. The focusing control
of the microscope was used as a micrometer. Fiber CSA was
calculated from the diameter and depth, assuming an elliptical
circumference, and was corrected for the 20% swelling that is
known to occur during skinning (Moss, 1979). Diameter and
depth were measured at three different locations along the length
of each fiber and the mean was considered representative of
cell dimensions. For the mechanical recording, relaxing and
activating solutions contained (in mM) 4 Mg-ATP, 1 free Mg2+,
20 imidazole, 7 EGTA, 14.5 creatine phosphate, and KCl to adjust
the ionic strength to 180 mM and pH 7.0. The concentrations
of free Ca2+ were 10−9 M (relaxing solution) and 10−4.5 M
(activating solution), expressed as pCa2+ (i.e., -log [Ca2+]).
Apparent stability constants for Ca2+-EGTA were corrected for
temperature (15◦C) and ionic strength (180 mM). The computer
program Fabiato (Fabiato, 1988) was used to calculate the
concentration of each metal, ligand, and metal-ligand complex.
Immediately preceding each activation the fiber was immersed
for 10–20 s in a solution with a reduced Ca2+-EGTA buffering
capacity. This solution is identical to the relaxing solution
except that the EGTA concentration is reduced to 0.5 mM,
which results in a more rapid attainment of steady force during
subsequent activation. Force was measured by the slack-test
procedure (Edman, 1979). This was calculated as the difference
between the maximal steady-state isometric force in activating
solution and the resting force measured in the same segment
while in the relaxing solution. Maximal force production was
normalized to CSA (specific force, absolute force (P0)/CSA). For
contractile measurements a strict acceptance criteria is applied.
A muscle fiber was accepted and included in the analyses: (i) if
the sarcomere length of a single muscle fiber changed <0.10µm
between relaxation andmaximum activation, (ii) if maximal force
changed<10% from first to seventh activation (Moss, 1979).
Myosin Heavy Chain (MyHC) Isoform
Expression
After mechanical recordings, each skinned fiber or two 10µm
diaphragm cryo-sections from the midcostal region were placed
in sample buffer (7.43ml distilled water, 2.1ml Glycerol,
1.4ml 10% SDS, 1.75 of 0.5M Trisbuffer pH6.8, 0.32ml
bromophenol blue, 32.4mg Dithiothreitol, 1ml Leupeptin) in
a plastic micro-centrifuge tube and stored at −180◦C for
subsequent electrophoretic analysis. MyHC isoform composition
of fibers was then determined by 6% SDS-PAGE (Figure 1). The
acrylamide concentration was 4% (wt/vol) in the stacking gel
and 6% in the running gel; the gel matrix included 30% glycerol.
Sample loads were kept small (equivalent to ∼0.05mm of fiber
segment) to improve the resolution of the myosin heavy chain
bands (types I, IIa, IIx, and IIb). Electrophoresis was performed
at 120V for 20–22 h with a Tris–glycine electrode buffer
(pH8.3) at 10◦C (SE 600 vertical slab gel unit, Hoefer Scientific
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FIGURE 1 | Typical myosin heavy chain (MyHC) isoform expression
from control rat diaphragm muscle was determined by 6% SDS-PAGE.
Types IIa, IIx, IIb, and I.
Instruments). The gels were silver-stained and subsequently
scanned in a soft laser densitometer (Molecular Dynamics) with
a high spatial resolution (50µm pixel spacing) and 4096 optical
density levels.
Immunoblotting
Ten sections from the midcostal part of the diaphragm
were dissolved in SDS buffer (50mM Tris-HCl, 2%SDS, 0.1%
bromophenol blue, 10% glycerol, and 2%β-mercaptoethanol,
pH 8.8), heated for 2min at 95◦C and total protein was
quantified using the Pierce 660 nm Protein Assembly Assay
(Thermo Scientific). Equal amounts of protein were separated
on SDS-polyacrylamide gels (Mini-PROTEAN 3 Cell, Bio-Rad
Laboratories) at constant 120 volts for 90min. Acrylamide
concentrations were 4 and 12% (w/v) in stacking and
running gels respectively, and the gel matrix included 10%
glycerol. Separated proteins were transferred to poly(vinylidene
difluoride) membranes (Immobilon-P, Millipore). Membranes
were blocked with 3% non-fat milk powder in Tris-buffered
saline containing Tween 20 for 1 h and incubated overnight at
4◦C with Hsp72- (SMC-100B, StressMarq) and actin (sc-1616,
Santa Cruz Biotechnology Inc.) primary antibodies and then
with HRP secondary antibodies (anti-mouse, GE Healthcare,
and anti-goat, Santa Cruz Biotech). Membranes were digitized
with ECL 500 Western Blotting Detection Agent Kit (Amersham
Biosciences) and imaging system (Odyssey, LI-CORBiosciences).
Band densities were quantified with Image Studio Lite analysis
software (LI-COR Biosciences) and normalized to actin.
Total RNA Isolation and Quantification
Total ribosomal nucleic acid (RNA) was extracted from frozen
diaphragm muscle tissue (10–30mg) using QiagenRNeasy R©
Mini Kit (Qiagen, Inc., Valencia, CA). Muscle tissue was
homogenized using a motor homogenizer (Eurostar Digital,
IKAWerke). QIAshredderTM columns (Qiagen Inc., Valencia,
CA) were used to disrupt DNA. Total RNA was eluted from
RNeasy R© Mini columns with 30µl of RNase-free water. RNA-
concentrations were then quantified using nanodrop 1000
spectrophotometer (Thermofisher Scientific, MA, USA).
Real Time Polymerase Chain Reaction
(qPCR)
qRT-PCR was used to quantify the mRNA levels for rat atrogin-
1, MuRF1. 300 ng of total RNA from diaphragm samples were
reverse transcribed to cDNA using Qscript cDNA supermix
(Quanta Biosciences, USA). cDNA was amplified in duplicate
using MyiQTM single color real time PCR detection system
(Bio-Rad Laboratories, Inc., Hercules, CA, USA). Each reaction
was performed in a 20µl volume with SYBR R© Green master
mix using the manufactures instructions. The thermal cycling
conditions include 95◦C for 10min, followed by 50 cycles of a
two-step PCR with denaturation at 95◦C for 15 s and a combined
annealing and extension step at 60◦C for 1 min. Taqman primers
were designed using the software Primer Express R©(Applied
Biosystems, Foster City, CA, USA), ordered from Sigma Aldrich
(Sigma-Aldrich St Louis, Missouri, USA). When optimizing each
PCR, the PCR products were run on 2% agarose gels to ensure
that primer–dimer formation was not occurring. Threshold cycle
(Ct) data obtained from running qRT-PCR and analyzed using
11Ct, these values were normalized against GAPDH.
Statistical Analysis
Means and standard error of the mean were calculated according
to standard procedures. A two-way ANOVA was used for the
analysis of the diaphragm single fibers. A one-way ANOVA was
used to analyze Hsp72 protein expression, MuRF1 and atrogin-1
gene expression. p< 0.05 was considered statistically significant.
RESULTS
Effects of 5 Days CMV With and Without
BGP-15 on Diaphragm Single Muscle Fiber
Cross Sectional Area and Diaphragm
Muscle Myosin Heavy Chain Isoform
Composition
A total of 306 diaphragm muscle fibers met the acceptance
criteria and were included in this study. Averages were based
on an average of 13 fibers per animal. The fiber cross sectional
area (CSA) from the old control animals was significantly
larger (p < 0.05) than in young adult controls (Figure 2). Five
days deep sedation, neuromuscular blockade (NMB) and CMV
resulted in a compensatory hypertrophy (p < 0.05) in the
young. In the old control animals, there is a trend toward an
increased CSA, although not statistically significant (Figure 2).
BGP-15 administration had no significant effect on muscle fiber
size compared with untreated animals during 5 days CMV
irrespective animal age (Figure 2). The IIx MyHC isoform was
dominant in all groups and there were no statistically significant
differences in MyHC isoform expression between groups in
response to age, CMV or BGP-15 administration (Figure 3).
Effects of 5 Days CMV With and Without
BGP-15 on Diaphragm Single Muscle Fiber
Specific and Absolute Force
An age-related decline in force upon maximum Ca2+ activation
normalized to muscle fiber CSA (specific force) was observed in
controls (p< 0.001). In both young and old animals, a significant
decrease exceeding 20% (p < 0.001 and p < 0.01, respectively)
was observed in specific force after 5 days mechanical ventilation
compared with the control group. Furthermore, systemic
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FIGURE 2 | Individual rat single diaphragm muscle fiber cross
sectional area (CSA) measured at fixed sarcomere length in control
animals (individual rats: young n = 4 and old n = 2) compared with
age-matched animals exposed to CMV for 5 days without (individual
rats: young n = 3 and old n = 2) and with BGP-15 (individual rats: young
n = 3 and old n = 3). Values are averages of individual data from the different
animals and the red line indicates the average for each group. (Filled circles,
young; open circles, old; red line, group average). Significance level, *p < 0.05.
administration of BGP-15 had a significant positive effect (P <
0.01) on the specific force in the young, but not in the old animals
(Figure 4A). Absolute muscle force followed a similar pattern as
specific force (Figure 4B).
Cacciani and co-workers (Cacciani et al., 2014) have
previously reported that the effects of 5 days CMV on specific
force, absolute force and muscle fiber CSA were independent of
the MyHC isoform expressed in the fiber. The effects of BGP-15
administration on muscle fiber size, specific and absolute force
were also independent of MyHC isoform expression (Table 1).
Effects of 5 Days CMV With and Without
BGP-15 on Hsp72 Expression in
Diaphragm Muscle
Hsp72 protein levels did not differ between young and old
animals in the control group or after 5 days CMV. However, the
increase (p < 0.05) in Hsp72 levels observed in response to 5
days BGP-15 administration in mechanically ventilated rats was
restricted to the young animals (Figure 5).
Effect of 5 Days CMV With and Without
BGP-15 on Atrogene mRNA Expression
The most striking observation that we made was an increased
expression of MuRF1 in only the young in response to 5 days
CMV+BGP-15 compared to control values and to 5 days CMV
alone (Figure 6A). Furthermore, we show that the transcriptional
regulation of MuRF1 and atrogin-1 showed an initial trend of
an upregulation after 5 days CMV in the young, however in the
old the expression of both atrogene’s appeared to be unaltered
by 5 days CMV or by BGP-15 (Figures 6A,B). In both instances
neither was seen to be statistically different in comparison to
control values.
DISCUSSION
This study is a continuation of previous studies from our group
investigating the effects of BGP-15 administration on diaphragm
muscle structure and function in young Sprague Dawley rats and
aging-related effects of long-term (5 days) CMV on diaphragm
muscle function in F344 BN hybrid rats (Cacciani et al., 2014;
Salah et al., 2016). The main aim of the present pilot study
was to test whether the effects of BGP-15, a Hsp chaperone
co-inducer, that alleviates diaphragm contractile dysfunction in
young rats, would have a more pronounced beneficial effect in
old animals due to a known compromised Hsp protection in old
age (Blake et al., 1991; Dodd et al., 2009). In accordance with
our hypothesis, BGP-15 had a very strong and positive effect on
diaphragm muscle function and Hsp72 expression, but opposite
to the original hypothesis this effect was primarily observed in the
young and not in the old.
The Effect of CMV and BGP-15 on Specific
Force
A dramatic decline in force production was observed after
5 days of CMV in both the young and old age groups in
agreement with previous reports in rats (Powers et al., 1985;
Le Bourdelles et al., 1994; Cacciani et al., 2014; Corpeno
et al., 2014), baboons (Anzueto et al., 1997) and piglets (Radell
et al., 2002; Ochala et al., 2011). This loss of specific force
may be attributed to a lower number of myosin cross-bridges
per area unit due to the preferential slowing of contractile
protein synthesis and/or accelerated destruction of the contractile
machinery of the muscle occurring in the ICU (Helliwell et al.,
1998; Ochala and Larsson, 2008; Derde et al., 2012; Cohen
et al., 2015). It has become more clear that specific ubiquitin
ligases play a prominent role (Sandri, 2008) via the muscle
ring finger 1 (MuRF1) and muscle atrophy F-box (MAFbx)
which greatly promotes the degradation of the molecular motor
myosin and related contractile proteins in the ICU and during
general disuse conditions (Schiaffino and Mammucari, 2011).
Surprisingly we observed an up regulation of MuRF1 gene
expression in the young rats after 5 days CMV and BGP-15
treatment in conjunction with an increased force production. To
date, MuRF1 and MAFbx mRNA expression have been shown
to be elevated at some point during every condition that induces
skeletal muscle atrophy (Bodine and Baehr, 2014). In addition,
MuRF1 and MAFbx are transiently expressed at the onset of
reloading following disuse atrophy (Slimani et al., 2012). Thus, it
has become clear that the expression of MuRF1 varies over a time
period demonstrating the importance of time-resolved analyses
of the atrogenes.
In accordance with our recent findings in young Sprague
Dawley rats exposed to 10 days of CMV (Salah et al., 2016),
administration of BGP-15 had a significant positive effect
on the force-generating capacity of diaphragm muscle fibers
irrespective of muscle fiber type. However, this effect was only
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FIGURE 3 | Myosin heavy chain isoform expression (%) from cross sections in young and old rats in control, 5 days CMV and 5 days CMV+BGP-15
groups. (Black, type I; white, type IIA; stripe, type IIX; gray, type IIB). Values are % + SEM.
FIGURE 4 | Individual rat single diaphragm muscle fiber. (A) specific force (Po/CSA) and (B) absolute force (Po) measured at fixed sarcomere length in control
animals (individual rats: young n = 4 and old n = 2) compared with age-matched animals exposed to CMV for 5 days without (individual rats: young n = 3 and old n =
2) and with BGP-15 (individual rats: young n = 3 and old n = 3). Values are averages of individual data from the different animals and the red line indicates the average
for each group. (Filled circles, young; Open circles, old; red line, group average). Significance level, *p < 0.05, **p < 0.01, ***p < 0.001.
observed in the young and not in the old animals, i.e., specific
force was ∼60% lower in the old animals after 5 days of
CMV regardless of BGP-15 treatment or not. The restored
force generating capacity in the young was associated with an
increased Hsp72 expression (Figure 5). BGP-15 may interfere
with membrane hyper-structures via their highly specific lipid
interactions to enhance stress signals that activate Hsp genes
and prolong the binding of HSF-1 to respective DNA elements
(Gombos et al., 2011). A vast amount of data support that
Hsp’s are induced through remodeling cell membranes (Vigh
et al., 2007; Gombos et al., 2011). Thus, the up-regulation
of Hsp72 may contribute to the maintenance of muscle fiber
integrity, facilitating muscle regeneration and recovery (Senf,
2013). In a recently published paper from our group on the
pathophysiological mechanisms underlying the impaired specific
force in response to CMV in diaphragm muscle fibers from
young Sprague Dawley rats, it was clearly demonstrated that the
loss of specific force was, at least in part, due to an impaired
function of the motor protein myosin due to post-translational
protein modifications (PTMs). Furthermore, the loss of force
was reversed with BGP-15, in parallel with a partial PTM
reversal and myosin function (Salah et al., 2016). Conversely
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TABLE 1 | Specific force, cross sectional area (CSA) and absolute force from single diaphragm muscle fibers exposed to 5 days controlled mechanical
ventilation + BGP-15, expressing different myosin heavy chain isoforms.
Fiber type Specific force CSA Po
(N/cm2) ± S.E.M. (µm2) ± S.E.M. (µN) ± S.E.M.
Young Old Young Old Young Old
I (8/13) 18 ± 4 5.2 ± 0.8 882 ± 169 1016 ± 150 128 ± 19 56 ± 6
IIA (2/1) 26 ± 7 8.4 575 ± 125 720 143 ± 10 61
IIB (2/0) 10 ± 2 869 ± 378 82 ± 18
IIX (7/12) 14 ± 3 5.6 ± 0.9 1023 ± 128 1004 ± 118 124 ± 11 48 ± 4
IIX, I (3/1) 9 ± 1 3.8 606 ± 33 655 59 ± 5.50 25
IIX, IIA (3/2) 20 ± 1 7.7 ± 1.2 531 ± 108 762 ± 20 107 ± 23 59 ± 8
IIX – IIB (1/1) 11 ± 1 7.1 900 ± 194 1032 103 ± 6 74
I-IIA-IIX-IIB (1/1) 11 4.4 1156 1289 132 58
The values are means ± SEM (young/old), number of fibers per group.
FIGURE 5 | Western blot analyses of the Hsp72 protein expression normalized to actin contents in the diaphragm in control animals (individual rats:
young n = 4 and old emphn = 2) compared with the age-matched animals exposed to CMV for 5 days with (individual rats: young n = 3 and old n = 2)
and without BGP-15 (individual rats: young n = 3 and old n = 3). (Black bars, young; white bars, old). Values are means + SEM. Significance level, *p < 0.05.
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FIGURE 6 | (A) MuRF1 gene expression (B) Atrogin-1 mRNA expression, according to real time PCR in the Diaphragm. Control animals (individual rats: young n = 4
and old n = 2) compared with age-matched animals exposed to CMV for 5 days without (individual rats: young n = 3 and old n = 2) and with BGP-15 (individual rats:
young n = 3 and old n = 3). Values are means of starting quantities + SEM. (Black, young; white, old. Significance level, **p < 0.01, ***p < 0.001.
Hsp72 expression is decreased duringmuscle inactivity and aging
and evidence supports the loss of Hsp72 as a key mechanism
that may drive muscle atrophy, contractile dysfunction and
reduced regenerative capacity associated with these conditions
(Singh et al., 2006; Senf et al., 2008). In old rats, BGP-15
failed to activate the potential events described above and
it did not promote up-regulation of the induced form of
Hsp70, Hsp72 in the diaphragm muscle. However, it cannot be
excluded that there is an aging-related shift in the dose-response
relationship and an increased amount of BGP-15may be required
to improve diaphragm function old age. Thus, dose-response
experiments deserve further scientific attention in the old
animals.
The Effect of CMV With the Addition of
BGP-15 on CSA
In accordance with our previous observation, a compensatory
muscle fiber hypertrophy was observed in young and old F344-
BN hybrid rats in response to 5 days CMV (Cacciani et al.,
2014). Furthermore, we show that BGP-15 had no additive
effect to CSA over 5 days CMV in either young or old and
that CSA remained constant in this time period. The premise
that disuse induces muscle fiber atrophy is widely accepted and
has essentially become physiological dogma in the literature.
However, this concept has been challenged and there is evidence
that the diaphragm does not atrophy as a result of inactivity
and an initial, albeit transient, hypertrophy has been reported
in diaphragm muscle fibers expressing the type I and IIa MyHC
isoforms in response to phrenicotomy or TTX nerve block (Sieck
and Mantilla, 2013). The idea of muscle fiber hypertrophy has
been alluded to in various models; hypertrophy has been seen
previously in a porcine model (Radell et al., 2002), which also
demonstrated a decline in in vivo diaphragm function. Kavazis
et al (Kavazis et al., 2007) also showed that in male F344-BN
rats aging resulted in an increase in the CSA of type IIA fibers.
Furthermore, it has been suggested that both hypertrophy and
atrophy may occur in skeletal muscle with the aging process.
Moreover, a study undertaken in cardiac tissue has demonstrated
a similar pattern (atrophy and hypertrophy) in senescent hearts
of F344-BN rats (Wanagat et al., 2002). This can be matched
to our similar finding in the diaphragm, being consistent with
the idea that this pattern occurs in muscles that remain highly
activated with aging. Pardo and co-workers suggested that the
age related increases in muscle stiffness might be responsible for
the altered response of the AKT and IKK signaling pathways to
the mechanical stimulation, which can in turn affect the FoXO1
and FoXO activity (Pardo et al., 2008). Thus, these changes may
be related to age and CMV changes in mechano-sensing and
mechano-transduction pathways.
It is established that Hsp70 has an intracellular effect on
the inhibition of nuclear factor κB (NF-κB) activation, which
has profound implications for immunity, inflammation, cell
survival and apoptosis. Hsp70 blocks NF-κB activation at
different levels. The inhibition of these transcriptional pathways
may explain the prevention of muscle-fiber atrophy by Hsp70,
since NF-κB and FoxO are independently sufficient to cause
skeletal muscle atrophy (Sandri et al., 2004). Furthermore, the
inhibitory potential of Hsp70 over apoptosis occurs via many
different intracellular downstream pathways (e.g., JNK, NF-
κB and Akt), which are directly and indirectly blocked by
Hsp70. Collectively, these mechanisms underlie Hsp70 anti-
apoptotic effects in cells under stress conditions (Thiago Gomes
Heck et al., 2012). This and further evidences suggest that
Hsp70 inhibits key signaling pathways for muscle atrophy
(Thiago Gomes Heck et al., 2012) and potentially be an
explanation for the hypertrophy demonstrated. The hypertrophy
is not incompatible with variations in the contractile protein
contents (described in the previous section) but probably means
a change in the inter-myofilament spacing or a change in
the amount of myoplasma with preserved inter-myofilament
spacing.
Study Limitation and Future Work
The small number of animals in this study limits the detection
of significant changes in the population, i.e., type II error. The
labor intense and technically difficult experimental rat model
Frontiers in Physiology | www.frontiersin.org 8 September 2016 | Volume 7 | Article 417
Ogilvie et al. BGP-15 and Diaphragm Function
mimicking the ICU condition, requiring extensive monitoring
24 h per day during the 5-day experimental period, and the
difficulty in obtaining old F344-BN hybrid animals has limited
the number of animals included in the young and old groups.
This limitation is acknowledged and a confirmatory follow up
study is needed in a larger population of animals. However, we
put forward from the present results that we have ascertained
a valid model for further investigating this intervention and to
applying it to a highly relevant and necessary topic of research.
In addition to increasing the total number of rats, future work
would have to focus on the molecular mechanisms underlying
the differences we found in the present study. First we will have
to clearly understand why specific force is restored in BGP-15
treated young rats and why this does not occur in old rat. As
is mentioned previously in a recently published paper from our
group the role of PTM has become evident as to playing a major
role and thus it would be advantageous to further investigate the
role in relation to the F344-BN hybrid rats and the impact of
aging.
CONCLUSION
Significant age-specific differences were observed in control
diaphragm fibers and in the response to 5 days CMV. Further,
BGP-15 had a strong positive effect on diaphragm muscle fiber
function and Hsp72 expression after 5 days CMV, but this effect
was restricted to the young animals. The underlying mechanisms
remain to be studied.
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